PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
SMALL CAP PRO
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 4.26 ▲ 0.00 (0.01%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Anavex Life Sciences Corp. | AVXL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0.1 | +2.4% | 4.26 | 4.35 | 4.06 | 4.14 | 4.16 | 17:15:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.1 | 4.25 | 0.15 | 3.53% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,723 | 688,042 | $ 4.2232 | $ 2.91M | 405.37k | 1.85 - 5.74 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:01:15 | formt | 339 | $4.26 | USD |
Anavex Life Sciences Corp. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 190.25M | 44.66M | $ -13.46M | -0.33 | 0.00 | 42.13M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | 5.96k | 23.10% |
Anavex Life Sciences Corp. News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/17/2018 | 17:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/17/2018 | 17:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/10/2018 | 17:18 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 5/10/2018 | 07:00 | GlobeNewswire Inc. | Anavex Life Sciences Reports Fiscal Second Quarter 2018.. |
| 5/09/2018 | 07:00 | GlobeNewswire Inc. | Anavex Life Sciences to Announce Fiscal Second Quarter 2018.. |
| 4/24/2018 | 12:36 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) |
| 4/20/2018 | 16:33 | Edgar (US Regulatory) | Current Report Filing (8-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVXL Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 3.97 | 4.35 | 3.77 | 4.1329 | 356k | 688k | 452k | 0.29 | 7.30% |
| 1 Month | 2.63 | 4.35 | 2.53 | 3.6880 | 172k | 5M | 739k | 1.63 | 61.98% |
| 3 Months | 2.65 | 4.35 | 1.85 | 3.0809 | 113k | 5M | 433k | 1.61 | 60.75% |
| 6 Months | 3.16 | 4.35 | 1.85 | 3.0052 | 104k | 5M | 369k | 1.1 | 34.81% |
| 1 Year | 5.59 | 5.74 | 1.85 | 3.6012 | 104k | 5M | 345k | -1.33 | -23.79% |
| 3 Years | 8.55 | 14.8399 | 1.85 | 5.1866 | 61k | 34M | 958k | -4.29 | -50.18% |
| 5 Years | 8.55 | 14.8399 | 1.85 | 5.1866 | 61k | 34M | 958k | -4.29 | -50.18% |
Anavex Life Sciences Corp. Description
| Anavex Life Sciences Corporation is engaged in the discovery and development of drug candidates. It develops drugs for treatment of diseases such as Alzheimer, prostate cancer, depression and neuropathic pain, among others. |
